Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

NCT03208868 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03208868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
August 5, 2013
Completion date
December 31, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver